Omnicell (OMCL)

• Market cap: $2.1B
• 1 day: 3.58%
• 5 days: 0.04%
• 1 month: 11.17%
• 3 months: 7.46%
• 6 months: 41.72%
• Year to date: 22.39%
• 1 year: 35.90%
• 5 years: -42.28%
• 10 years: 42.83%
• Sector: Information Technology
• Industry: Electronic Computers

About: Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.

Employees: 3,590

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

501% more call options, than puts

Call options by funds: $10M | Put options by funds: $1.67M

55% more capital invested

Capital invested by funds: $1.28B [Q2] → $1.99B (+$707M) [Q3]

50% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 34

7% more funds holding

Funds holding: 240 [Q2] → 257 (+17) [Q3]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]

3.73% less ownership

Funds ownership: 102.87% [Q2] → 99.14% (-3.73%) [Q3]

33% less repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 100

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $37 19% downside
• Avg. target: $50 9% upside
• High target: $64 40% upside

7 analyst ratings

• positive: 2 29%
• neutral: 5 71%
• negative: 0 0%

JP Morgan Anne Samuel 57% 1-year accuracy 4 / 7 met price target	4% downside $44	Neutral Maintained	21 Nov 2024
Barclays Stephanie Davis 55% 1-year accuracy 6 / 11 met price target	27% upside $58	Equal-Weight Maintained	31 Oct 2024
Craig-Hallum Matt Hewitt 29% 1-year accuracy 4 / 14 met price target	40% upside $64	Buy Maintained	31 Oct 2024
B of A Securities Allen Lutz 100% 1-year accuracy 6 / 6 met price target	25% upside $57	Neutral Downgraded	31 Oct 2024
Wells Fargo Stan Berenshteyn 60% 1-year accuracy 3 / 5 met price target	10% downside $41	Equal-Weight Maintained	14 Oct 2024